Notice
Recent Posts
Recent Comments
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 |
Tags
- case study
- Malaysia
- OTCBB
- Bank
- Letter of intent
- sk
- China Construction Bank
- PEF
- capital gate
- Japan Tobacco
- private equity
- buyout
- cgi korea
- Confidential Agreement
- nda
- hong kong
- Korea
- Merger
- Japan
- China
- securities
- CA
- LOI
- Korea M&A
- taiwan
- acquisition
- M&A
- Investment
- Acquistion
- CCB
Archives
- Today
- Total
Korea M&A Corporation
GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance
GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals (OncoMed) today announced a worldwide strategic alliance to discover, develop and market novel antibody therapeutics to target cancer stem cells which are believed to play a key role in the establishment, metastasis and recurrence of cancer. The alliance with GSK will be conducted through its Center of Excellencefor External Drug Discovery (CEEDD..
News/ETC
2007. 12. 15. 09:13